D. ARDIÇLI Et Al. , "Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay," EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , vol.33, pp.94-98, 2021
ARDIÇLI, D. Et Al. 2021. Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , vol.33 , 94-98.
ARDIÇLI, D., Haliloglu, G., GÖÇMEN, R., GÜNBEY, C., & TOPÇU, M., (2021). Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , vol.33, 94-98.
ARDIÇLI, DİDEM Et Al. "Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay," EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , vol.33, 94-98, 2021
ARDIÇLI, DİDEM Et Al. "Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay." EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , vol.33, pp.94-98, 2021
ARDIÇLI, D. Et Al. (2021) . "Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay." EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY , vol.33, pp.94-98.
@article{article, author={DİDEM ARDIÇLI Et Al. }, title={Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay}, journal={EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY}, year=2021, pages={94-98} }